Islet Hormone and Incretin Secretion in Cystic Fibrosis after Four Months of Ivacaftor Therapy

Rationale: Diabetes is associated with worse cystic fibrosis (CF) outcomes. The CFTR potentiator ivacaftor is suggested to improve glucose homeostasis in individuals with CF. Objectives: To test the hypothesis that clinically indicated ivacaftor would be associated with improvements in glucose toler...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Respir Crit Care Med
Main Authors: Kelly, Andrea, De Leon, Diva D., Sheikh, Saba, Camburn, Devaney, Kubrak, Christina, Peleckis, Amy J., Stefanovski, Darko, Hadjiliadis, Denis, Rickels, Michael R., Rubenstein, Ronald C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Thoracic Society 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6835076/
https://ncbi.nlm.nih.gov/pubmed/30130412
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201806-1018OC
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados